标题
Focused Libraries for Epigenetic Drug Discovery: The Importance of Isosteres
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 11, Pages 7231-7240
出版商
American Chemical Society (ACS)
发表日期
2021-05-27
DOI
10.1021/acs.jmedchem.1c00592
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development
- (2021) Pan Tang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors
- (2021) Helen E. Aylott et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bidentate Directing Groups: An Efficient Tool in C–H Bond Functionalization Chemistry for the Expedient Construction of C–C Bonds
- (2020) Supriya Rej et al. CHEMICAL REVIEWS
- Structurally novel PI3Kδ/γ dual inhibitors characterized by a seven-membered spirocyclic spacer: The SARs investigation and PK evaluation
- (2020) Qiangqiang Tao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Selective targeting of BD1 and BD2 of the BET proteins in cancer and immuno-inflammation
- (2020) Omer Gilan et al. SCIENCE
- Epigenetic Chemical Biology: Opportunities Beyond the Advances and Opportunities in Epigenetic Chemical Biology
- (2020) Jenna N Beyer et al. CHEMBIOCHEM
- The Design and Synthesis of a Highly Selective and In Vivo Capable Inhibitor of the Second Bromodomain (BD2) of the Bromodomain and Extra Terminal Domain (BET) Family of Proteins
- (2020) Alex Preston et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epigenetic Therapies for Cancer
- (2020) Susan E. Bates NEW ENGLAND JOURNAL OF MEDICINE
- The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells
- (2020) Kamira Maharaj et al. Blood Advances
- Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3
- (2019) Jark Böttcher et al. Nature Chemical Biology
- Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer
- (2019) Fatma M. Elmenier et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cancer's epigenetic drugs: where are they in the cancer medicines?
- (2019) Sorayya Ghasemi PHARMACOGENOMICS JOURNAL
- Organic synthesis provides opportunities to transform drug discovery
- (2018) David C. Blakemore et al. Nature Chemistry
- Profiling and Application of Photoredox C(sp3)–C(sp2) Cross-Coupling in Medicinal Chemistry
- (2018) Rui Zhang et al. ACS Medicinal Chemistry Letters
- Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth
- (2018) Jonathan B. Baell et al. NATURE
- Expanding the medicinal chemistry synthetic toolbox
- (2018) Jonas Boström et al. NATURE REVIEWS DRUG DISCOVERY
- Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection
- (2017) David A. DeGoey et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
- (2017) Loren M. Lasko et al. NATURE
- Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors
- (2017) Jayme L. Dahlin et al. Nature Communications
- Molecular inflation, attrition and the rule of five
- (2016) Paul D. Leeson ADVANCED DRUG DELIVERY REVIEWS
- Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors
- (2016) Florence F. Wagner et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The medicinal chemist's toolbox for late stage functionalization of drug-like molecules
- (2016) Tim Cernak et al. CHEMICAL SOCIETY REVIEWS
- KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases
- (2016) Roman P. Simon et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat
- (2016) Kevin W. Kuntz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent Progress in Histone Demethylase Inhibitors
- (2016) Tom E. McAllister et al. JOURNAL OF MEDICINAL CHEMISTRY
- Understanding the Complexity of Epigenetic Target Space
- (2016) Vineet Pande JOURNAL OF MEDICINAL CHEMISTRY
- Big Data from Pharmaceutical Patents: A Computational Analysis of Medicinal Chemists’ Bread and Butter
- (2016) Nadine Schneider et al. JOURNAL OF MEDICINAL CHEMISTRY
- The molecular hallmarks of epigenetic control
- (2016) C. David Allis et al. NATURE REVIEWS GENETICS
- Structure-Guided Discovery of Selective Antagonists for the Chromodomain of Polycomb Repressive Protein CBX7
- (2016) Chunyan Ren et al. ACS Medicinal Chemistry Letters
- Chemical Inhibitors of Epigenetic Methyllysine Reader Proteins
- (2015) Natalia Milosevich et al. BIOCHEMISTRY
- Kinase hinge binding scaffolds and their hydrogen bond patterns
- (2015) Li Xing et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery, design, and synthesis of indole-based EZH2 inhibitors
- (2015) Victor S. Gehling et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Small-Molecule Modulators of Methyl-Lysine Binding for the CBX7 Chromodomain
- (2015) Chunyan Ren et al. CHEMISTRY & BIOLOGY
- Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?
- (2015) Dean G. Brown et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small Molecule Inhibitors of Bromodomain–Acetyl-lysine Interactions
- (2014) Michael Brand et al. ACS Chemical Biology
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Late-Stage Fluorination: From Fundamentals to Application
- (2014) Michael G. Campbell et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition
- (2014) R. Marmorstein et al. Cold Spring Harbor Perspectives in Biology
- Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases
- (2013) Frank J. Dekker et al. DRUG DISCOVERY TODAY
- Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
- (2013) Olivier Mirguet et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases
- (2013) Zhanxin Wang et al. QUARTERLY REVIEWS OF BIOPHYSICS
- Structural Insights into Acetylated-Histone H4 Recognition by the Bromodomain-PHD Finger Module of Human Transcriptional Coactivator CBP
- (2013) Alexander N. Plotnikov et al. STRUCTURE
- Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments
- (2013) James R. Hitchin et al. MedChemComm
- Lead-Oriented Synthesis: A New Opportunity for Synthetic Chemistry
- (2012) Alan Nadin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
- (2012) Jueng Soo You et al. CANCER CELL
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- (2012) Sarah K Knutson et al. Nature Chemical Biology
- Vemurafenib: the first drug approved for BRAF-mutant cancer
- (2012) Gideon Bollag et al. NATURE REVIEWS DRUG DISCOVERY
- Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
- (2012) W. Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2
- (2012) Sharad K. Verma et al. ACS Medicinal Chemistry Letters
- Biology-Oriented Synthesis
- (2011) Stefan Wetzel et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Small-Molecule Ligands of Methyl-Lysine Binding Proteins
- (2011) J. Martin Herold et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
- (2011) David S. Hewings et al. JOURNAL OF MEDICINAL CHEMISTRY
- What Do Medicinal Chemists Actually Make? A 50-Year Retrospective
- (2011) W. Patrick Walters et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
- (2011) Stephen D. Roughley et al. JOURNAL OF MEDICINAL CHEMISTRY
- Factors Determining the Selection of Organic Reactions by Medicinal Chemists and the Use of These Reactions in Arrays (Small Focused Libraries)
- (2010) Tony W. J. Cooper et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules
- (2010) Warren R.J.D. Galloway et al. Nature Communications
- Monocyclic aromatic amines as potential human carcinogens: old is new again
- (2009) P. L. Skipper et al. CARCINOGENESIS
- An operational definition of epigenetics
- (2009) S. L. Berger et al. GENES & DEVELOPMENT
- Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
- (2009) Yanqi Chang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Physiochemical drug properties associated with in vivo toxicological outcomes
- (2008) Jason D. Hughes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)
- (2007) Joey L. Methot et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started